Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Sees Large Decline in Short Interest

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 100 shares, a drop of 75.0% from the December 31st total of 400 shares. Based on an average daily volume of 3,100 shares, the short-interest ratio is currently 0.0 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

Shares of HROWM stock traded up $0.13 during mid-day trading on Wednesday, hitting $26.58. 104 shares of the stock traded hands, compared to its average volume of 4,151. The stock’s fifty day moving average is $26.35 and its two-hundred day moving average is $26.36. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52-week low of $25.30 and a 52-week high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th will be paid a $0.7422 dividend. The ex-dividend date of this dividend is Wednesday, January 15th. This represents a $2.97 annualized dividend and a yield of 11.17%.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.